Early induction of interleukin-6 mRNA in the hippocampus and cortex of APPsw transgenic mice Tg2576

Neuroscience Letters

Volumn 301, Issue 1, 2001, Pages 54-58

  Tehranian, Roya ^a   Hasanvan, Homa ^b   Iverfeldt, Kerstin ^a   Post, Claes ^b,c   Schultzberg, Marianne ^b  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Melacure Therapeutics AB   (Sweden)

Author keywords

Alzheimer's disease; Amyloidosis; Cytokines; Inflammation

Indexed keywords

INTERLEUKIN 6;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL TISSUE; ARTICLE; ASTROCYTE; GENE INDUCTION; HIPPOCAMPUS; IMMUNE RESPONSE; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

AMYLOID BETA-PROTEIN PRECURSOR; AMYLOIDOSIS; ANIMALS; CASPASE 1; CEREBELLUM; CEREBRAL CORTEX; HIPPOCAMPUS; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MICE; MICE, TRANSGENIC; RNA, MESSENGER;

EID: 0035937650     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(01)01592-0     Document Type: Article

References (25)

1. Inflammation and Alzheimer's disease
2. Interleukin-6 and α-2-macroglobulin indicate an acute phase state in Alzheimer's disease cortices
3. Evidence for glial-mediated inflammation in aged APPsw transgenic mice
4. Interleukin-1-beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimers and de novo Parkinsons disease patients
5. Neurologic disease induced in transgenic mice by overexpression of interleukin-6
6. Expression of ced-3 and ced-9 homologs in Alzheimer's disease cerebral cortex
7. Hypersensitive cytokine response to β-amyloid 25-35 in astroglial cells from IL-1 receptor type I-deficient mice
8. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty
9. Microglial response to amyloid plaques in APPsw transgenic mice
10. Induction of tumour necrosis factor-α mRNA in the brain after peripheral endotoxin treatment: Comparison with interleukin-1 family and interleukin-6
11. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
12. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease
13. Transgenic mice expressing Alzheimer amyloid precursor protein
14. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice
15. IL-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients
16. Anti-inflammatory drugs and Alzheimer disease
17. Induction of cytokines in glial cells surrounding cortical β-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology
18. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid
19. Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients
20. A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease
21. Clinical trial of indomethacin in Alzheimer's disease
22. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
23. Regionally specific induction of ICE mRNA and enzyme activity in the rat brain and adrenal gland by LPS
24. Decreased interleukin-6 level in the cerebrospinal fluid of patients with Alzheimer-type dementia
25. Increased interleukin-1β converting enzyme expression and activity in Alzheimer disease